4//SEC Filing
Waltzman Roger J. 4
Accession 0001493152-24-040728
CIK 0001857044other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:05 PM ET
Size
5.6 KB
Accession
0001493152-24-040728
Insider Transaction Report
Form 4
Waltzman Roger J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-09+75,000→ 75,000 totalExercise: $1.10Exp: 2034-10-09→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001678987
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:05 PM ET
- Size
- 5.6 KB